These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33278505)

  • 1. The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Cai Y; Xing L; Yang T; Chai R; Wang J; Bao J; Shen W; Ding S; Chen G
    Neurosci Lett; 2021 Jan; 741():135540. PubMed ID: 33278505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine: Functions, Signaling, and Association with Neurological Diseases.
    Klein MO; Battagello DS; Cardoso AR; Hauser DN; Bittencourt JC; Correa RG
    Cell Mol Neurobiol; 2019 Jan; 39(1):31-59. PubMed ID: 30446950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic system and neurons: Role in multiple neurological diseases.
    Chen H; Li J; Huang Z; Fan X; Wang X; Chen X; Guo H; Liu H; Li S; Yu S; Li H; Huang X; Ma X; Deng X; Wang C; Liu Y
    Neuropharmacology; 2024 Dec; 260():110133. PubMed ID: 39197818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of dopaminergic signalling during larval zebrafish brain development: a tool for investigating the developmental basis of neuropsychiatric disorders.
    Souza BR; Tropepe V
    Rev Neurosci; 2011; 22(1):107-19. PubMed ID: 21615265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desire, disease, and the origins of the dopaminergic system.
    Sillitoe RV; Vogel MW
    Schizophr Bull; 2008 Mar; 34(2):212-9. PubMed ID: 18283047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin proteasome pathway in neuropsychiatric disorders.
    Cheon S; Dean M; Chahrour M
    Neurobiol Learn Mem; 2019 Nov; 165():106791. PubMed ID: 29398581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobehavioral changes arising from early life dopamine signaling perturbations.
    Areal LB; Blakely RD
    Neurochem Int; 2020 Jul; 137():104747. PubMed ID: 32325191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Elevation of proinflammatory cytokines level at early age as the risk factor of neurological and mental pathology development].
    Zubarev OE; Klimenko VM
    Ross Fiziol Zh Im I M Sechenova; 2011 Oct; 97(10):1048-59. PubMed ID: 22292271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.
    de Oliveira RW; Oliveira CL; Guimarães FS; Campos AC
    Acta Neuropsychiatr; 2019 Feb; 31(1):1-16. PubMed ID: 29764526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency: infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia).
    Berridge MJ
    Am J Physiol Cell Physiol; 2018 Feb; 314(2):C135-C151. PubMed ID: 29070492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and the regulation of cognition and attention.
    Nieoullon A
    Prog Neurobiol; 2002 May; 67(1):53-83. PubMed ID: 12126656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder-Related Phenotypes.
    Lu X; Song Y; Wang J; Cai Y; Peng S; Lin J; Lai B; Sun J; Liu T; Chen G; Xing L
    Am J Pathol; 2024 Jun; 194(6):1062-1077. PubMed ID: 38492733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders.
    Stahl SM
    Arch Gen Psychiatry; 1977 May; 34(5):509-16. PubMed ID: 140632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.
    van der Stelt M; Di Marzo V
    Eur J Pharmacol; 2003 Nov; 480(1-3):133-50. PubMed ID: 14623357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dopamine D4 receptor: biochemical and signalling properties.
    Rondou P; Haegeman G; Van Craenenbroeck K
    Cell Mol Life Sci; 2010 Jun; 67(12):1971-86. PubMed ID: 20165900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP; Kieling C; Rohde LA; Hutz MH
    Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.
    Swanson JM; Kinsbourne M; Nigg J; Lanphear B; Stefanatos GA; Volkow N; Taylor E; Casey BJ; Castellanos FX; Wadhwa PD
    Neuropsychol Rev; 2007 Mar; 17(1):39-59. PubMed ID: 17318414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin, GABA, and dopamine interplay in autism.
    Havranek T; Bacova Z; Bakos J
    Endocr Regul; 2024 Jan; 58(1):105-114. PubMed ID: 38656256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopaminergic system in attention deficit/hyperactivity disorder.
    Ohno M
    Congenit Anom (Kyoto); 2003 Jun; 43(2):114-22. PubMed ID: 12893970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.